Study Finds Cannabinoid Compounds Trigger Ferroptosis in Aggressive Brain Cancer Cells
- The study from Ankara Medipol University found that synthetic cannabinoids CP55-940 and WIN 55212-2 can induce ferroptosis, an iron-dependent form of cell death, in glioblastoma cells.
- Both compounds significantly reduced glioblastoma cell viability by increasing oxidative stress, the labile iron pool, lipid peroxidation, and affecting key markers like glutathione peroxidase-4 and transferrin receptor 1.
- A notable discovery was the increased expression of the transferrin receptor 1 gene, linking altered iron regulation to the promotion of ferroptosis in tumor cells.
- Since glioblastoma is typically resistant to apoptosis, ferroptosis induced by cannabinoids may offer a promising alternative therapeutic approach, though findings are currently limited to preclinical studies requiring further research.
According to a study published by The Journal of Pharmacology and Experimental Therapeutics. cannabinoid compounds may help kill glioblastoma cells by triggering ferroptosis, a form of iron-dependent cell death.
The study was conducted by researchers from Ankara Medipol University. It focused on glioblastoma multiforme, the most commonly diagnosed brain tumor, which is known for its poor prognosis, aggressive growth and high rate of recurrence.
Researchers examined two synthetic cannabinoid receptor agonists, CP55-940 and WIN 55212-2, to see how they affected glioblastoma cells. Although both compounds have previously been linked to neuroprotective and anticancer activity, the mechanisms behind those effects have remained unclear.
According to the study, both compounds significantly reduced cell viability while also increasing oxidative stress, the labile iron pool and lipid peroxidation, all of which are tied to ferroptosis. Researchers also found changes in several key markers associated with this form of cell death, including glutathione peroxidase-4 and transferrin receptor 1.
One of the study’s more notable findings was that both compounds significantly increased expression of the transferrin receptor 1 gene, which researchers said had not been shown before in this context. The compounds were also found to alter iron regulation in ways that appeared to help push glioblastoma cells toward ferroptosis.
Because glioblastoma is often resistant to apoptosis and other traditional cell death mechanisms, researchers say ferroptosis may provide an alternate path for destroying tumor cells. They conclude that CP55-940 and WIN 55212-2, as well as natural cannabinoids, warrant further consideration as potential therapeutic candidates, although the findings are limited to preclinical cell-based research and much more study is needed before any use in humans could be considered.